Qualitative Study of Student Financial Insecurity and Psychiatry (QUALIPEPSY)
A Qualitative Exploration of the Impact of Financial Insecurity on the Development of Psychiatric Disorders and the Use of Healthcare Services Among Students
Since the COVID-19 pandemic, mental health disorders have increased significantly, particularly among young people. In France, the proportion of young people aged 18 to 25 suffering from depression almost doubled between 2017 and 2021. This phenomenon particularly affects students, who are already identified as being at greater risk of mental health disorders than the general population. Medical students seem to be particularly vulnerable: in 2021, a national study showed very high rates of depression and suicidal thoughts in this population. The main factor associated with depression was the feeling of financial hardship.
Students often face multiple forms of insecurity. Financially, they have limited resources and struggle to cover their basic needs such as housing, food and healthcare. Socially, many experience significant isolation, particularly when they are away from their families or under pressure from their studies. All of this has a significant impact on their mental health. Unfortunately, many students do not seek help due to lack of time, resources, or awareness of support services. The 2021 study showed that only one-third of medical students suffering from depression received appropriate treatment.
The aim of the study is to explore the lived experiences of the students concerned in order to identify what they perceive as the various aspects of student precarity (housing, transport, isolation, financial difficulties, etc.) and the links they perceive between these and their psychological distress. This study will deepen our understanding of these factors by exploring students' lived experiences, and will bring to light elements not identified by quantitative studies.
調査の概要
詳細な説明
研究の種類
入学 (推定)
連絡先と場所
研究連絡先
- 名前:Marie Benhammani-Godard
- 電話番号:0033158411190
- メール:marie.godard@aphp.fr
研究連絡先のバックアップ
- 名前:Cédric LEMOGNE, MC, PhD
- 電話番号:0033 1 42 34 85 76
- メール:cedric.lemogne@aphp.fr
研究場所
-
-
IDF
-
Paris、IDF、フランス、75014
- Adult Psychiatry Department - Hôtel-Dieu Hospital
-
コンタクト:
- Cédric LEMOGNE, MD, PhD
- 電話番号:0033 1 42 34 85 76
- メール:cedric.lemogne@aphp.fr
-
-
参加基準
適格基準
就学可能な年齢
- 大人
- 高齢者
健康ボランティアの受け入れ
サンプリング方法
調査対象母集団
説明
Inclusion Criteria:
- A student enrolled at Paris Sciences et Lettres (PSL) University or the Faculty of Health Sciences at Université Paris Cité (UPC),
- Aged 18 or over,
- Fluent in French,
- be a student,
- have used the PPOP scheme,
- not object to participating after receiving clear information.
Exclusion Criteria:
- Participants under the age of 18,
- not enrolled at PSL universities or the UPCS Faculty of Health Sciences,
- insufficient proficiency in French to conduct an interview,
- refusal to participate,
- clinical vulnerability deemed incompatible by the referring consultant.
研究計画
研究はどのように設計されていますか?
デザインの詳細
コホートと介入
グループ/コホート |
介入・治療 |
|---|---|
|
Patients
Students
|
半構造化インタビュー
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Semi-structured interview
時間枠:Day of inclusion
|
This is an exploratory, inductive qualitative study.
The aim is not to measure but to explore and understand these students' lived experiences, without any preconceived assumptions
|
Day of inclusion
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Semi-structured interview
時間枠:Day of inclusion
|
This is an exploratory, inductive qualitative study.
The aim is not to measure but to explore and understand these students' lived experiences, without any preconceived assumptions
|
Day of inclusion
|
協力者と研究者
協力者
捜査官
- スタディチェア:Ariel FRAJERMAN, MD、Institut National de la Santé Et de la Recherche Médicale, France
- スタディディレクター:Jordan SIBEONI, MD, PhD、Institut National de la Santé Et de la Recherche Médicale, France
研究記録日
主要日程の研究
研究開始 (推定)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
キーワード
その他の研究ID番号
- APHP260752 - QUALIPEPSY
- 2026-A01287-44 (その他の識別子:France : Ministry of Health)
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。